Global Antibody Drug Conjugates Contract Manufacturing Market Growth (Status and Outlook) 2022-2028

Publication Month: Sep 2022 | No. of Pages: 111 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

The global market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Antibody Drug Conjugates Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Antibody Drug Conjugates Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Antibody Drug Conjugates Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Antibody Drug Conjugates Contract Manufacturing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Antibody Drug Conjugates Contract Manufacturing players cover Lonza Group, Piramal Pharma Solutions, Abbvie, Novasep and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Antibody Drug Conjugates Contract Manufacturing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Antibody Drug Conjugates Contract Manufacturing market, with both quantitative and qualitative data, to help readers understand how the Antibody Drug Conjugates Contract Manufacturing market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Antibody Drug Conjugates Contract Manufacturing market and forecasts the market size by Type (IgG1, IgG2 and IgG4), by Application (Solid Tumors and Hematological Malignancies.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
IgG1
IgG2
IgG4
Segmentation by application
Solid Tumors
Hematological Malignancies
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Lonza Group
Piramal Pharma Solutions
Abbvie
Novasep
Merck
Cambrex Corporation
Recipharm
Thermo Fisher Scientific
Cerbios-Pharma
Sterling Pharma Solutions
ADC Biotechnology
Ajinomoto Bio-Pharma Services
BOC Sciences
BSP Pharmaceuticals
CARBOGEN AMCIS
Goodwin Biotechnology
Chapter Introduction
Chapter 1: Scope of Antibody Drug Conjugates Contract Manufacturing, Research Methodology, etc.
Chapter 2: Executive Summary, global Antibody Drug Conjugates Contract Manufacturing market size and CAGR, Antibody Drug Conjugates Contract Manufacturing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Antibody Drug Conjugates Contract Manufacturing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Antibody Drug Conjugates Contract Manufacturing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Antibody Drug Conjugates Contract Manufacturing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Lonza Group, Piramal Pharma Solutions, Abbvie, Novasep, Merck, Cambrex Corporation, Recipharm, Thermo Fisher Scientific and Cerbios-Pharma, etc.
Chapter 14: Research Findings and Conclusion

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size 2017-2028
2.1.2 Antibody Drug Conjugates Contract Manufacturing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Antibody Drug Conjugates Contract Manufacturing Segment by Type
2.2.1 IgG1
2.2.2 IgG2
2.2.3 IgG4
2.3 Antibody Drug Conjugates Contract Manufacturing Market Size by Type
2.3.1 Antibody Drug Conjugates Contract Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type (2017-2022)
2.4 Antibody Drug Conjugates Contract Manufacturing Segment by Application
2.4.1 Solid Tumors
2.4.2 Hematological Malignancies
2.5 Antibody Drug Conjugates Contract Manufacturing Market Size by Application
2.5.1 Antibody Drug Conjugates Contract Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application (2017-2022)
3 Antibody Drug Conjugates Contract Manufacturing Market Size by Player
3.1 Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Players
3.1.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2020-2022)
3.1.2 Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Players (2020-2022)
3.2 Global Antibody Drug Conjugates Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibody Drug Conjugates Contract Manufacturing by Regions
4.1 Antibody Drug Conjugates Contract Manufacturing Market Size by Regions (2017-2022)
4.2 Americas Antibody Drug Conjugates Contract Manufacturing Market Size Growth (2017-2022)
4.3 APAC Antibody Drug Conjugates Contract Manufacturing Market Size Growth (2017-2022)
4.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size Growth (2017-2022)
4.5 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022)
5.2 Americas Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022)
5.3 Americas Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2017-2022)
6.2 APAC Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022)
6.3 APAC Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antibody Drug Conjugates Contract Manufacturing by Country (2017-2022)
7.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022)
7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing by Region (2017-2022)
8.2 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022)
8.3 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.1 Global Antibody Drug Conjugates Contract Manufacturing Forecast by Regions (2023-2028)
10.1.1 Global Antibody Drug Conjugates Contract Manufacturing Forecast by Regions (2023-2028)
10.1.2 Americas Antibody Drug Conjugates Contract Manufacturing Forecast
10.1.3 APAC Antibody Drug Conjugates Contract Manufacturing Forecast
10.1.4 Europe Antibody Drug Conjugates Contract Manufacturing Forecast
10.1.5 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Forecast
10.2 Americas Antibody Drug Conjugates Contract Manufacturing Forecast by Country (2023-2028)
10.2.1 United States Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.2.2 Canada Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.2.3 Mexico Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.2.4 Brazil Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.3 APAC Antibody Drug Conjugates Contract Manufacturing Forecast by Region (2023-2028)
10.3.1 China Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.3.2 Japan Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.3.3 Korea Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.3.4 Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.3.5 India Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.3.6 Australia Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.4 Europe Antibody Drug Conjugates Contract Manufacturing Forecast by Country (2023-2028)
10.4.1 Germany Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.4.2 France Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.4.3 UK Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.4.4 Italy Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.4.5 Russia Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.5 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Forecast by Region (2023-2028)
10.5.1 Egypt Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.5.2 South Africa Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.5.3 Israel Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.5.4 Turkey Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.5.5 GCC Countries Antibody Drug Conjugates Contract Manufacturing Market Forecast
10.6 Global Antibody Drug Conjugates Contract Manufacturing Forecast by Type (2023-2028)
10.7 Global Antibody Drug Conjugates Contract Manufacturing Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Lonza Group
11.1.1 Lonza Group Company Information
11.1.2 Lonza Group Antibody Drug Conjugates Contract Manufacturing Product Offered
11.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Lonza Group Main Business Overview
11.1.5 Lonza Group Latest Developments
11.2 Piramal Pharma Solutions
11.2.1 Piramal Pharma Solutions Company Information
11.2.2 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product Offered
11.2.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Piramal Pharma Solutions Main Business Overview
11.2.5 Piramal Pharma Solutions Latest Developments
11.3 Abbvie
11.3.1 Abbvie Company Information
11.3.2 Abbvie Antibody Drug Conjugates Contract Manufacturing Product Offered
11.3.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Abbvie Main Business Overview
11.3.5 Abbvie Latest Developments
11.4 Novasep
11.4.1 Novasep Company Information
11.4.2 Novasep Antibody Drug Conjugates Contract Manufacturing Product Offered
11.4.3 Novasep Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novasep Main Business Overview
11.4.5 Novasep Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Antibody Drug Conjugates Contract Manufacturing Product Offered
11.5.3 Merck Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Cambrex Corporation
11.6.1 Cambrex Corporation Company Information
11.6.2 Cambrex Corporation Antibody Drug Conjugates Contract Manufacturing Product Offered
11.6.3 Cambrex Corporation Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Cambrex Corporation Main Business Overview
11.6.5 Cambrex Corporation Latest Developments
11.7 Recipharm
11.7.1 Recipharm Company Information
11.7.2 Recipharm Antibody Drug Conjugates Contract Manufacturing Product Offered
11.7.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Recipharm Main Business Overview
11.7.5 Recipharm Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product Offered
11.8.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 Cerbios-Pharma
11.9.1 Cerbios-Pharma Company Information
11.9.2 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product Offered
11.9.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Cerbios-Pharma Main Business Overview
11.9.5 Cerbios-Pharma Latest Developments
11.10 Sterling Pharma Solutions
11.10.1 Sterling Pharma Solutions Company Information
11.10.2 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product Offered
11.10.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Sterling Pharma Solutions Main Business Overview
11.10.5 Sterling Pharma Solutions Latest Developments
11.11 ADC Biotechnology
11.11.1 ADC Biotechnology Company Information
11.11.2 ADC Biotechnology Antibody Drug Conjugates Contract Manufacturing Product Offered
11.11.3 ADC Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 ADC Biotechnology Main Business Overview
11.11.5 ADC Biotechnology Latest Developments
11.12 Ajinomoto Bio-Pharma Services
11.12.1 Ajinomoto Bio-Pharma Services Company Information
11.12.2 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product Offered
11.12.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Ajinomoto Bio-Pharma Services Main Business Overview
11.12.5 Ajinomoto Bio-Pharma Services Latest Developments
11.13 BOC Sciences
11.13.1 BOC Sciences Company Information
11.13.2 BOC Sciences Antibody Drug Conjugates Contract Manufacturing Product Offered
11.13.3 BOC Sciences Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 BOC Sciences Main Business Overview
11.13.5 BOC Sciences Latest Developments
11.14 BSP Pharmaceuticals
11.14.1 BSP Pharmaceuticals Company Information
11.14.2 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product Offered
11.14.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 BSP Pharmaceuticals Main Business Overview
11.14.5 BSP Pharmaceuticals Latest Developments
11.15 CARBOGEN AMCIS
11.15.1 CARBOGEN AMCIS Company Information
11.15.2 CARBOGEN AMCIS Antibody Drug Conjugates Contract Manufacturing Product Offered
11.15.3 CARBOGEN AMCIS Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 CARBOGEN AMCIS Main Business Overview
11.15.5 CARBOGEN AMCIS Latest Developments
11.16 Goodwin Biotechnology
11.16.1 Goodwin Biotechnology Company Information
11.16.2 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product Offered
11.16.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Goodwin Biotechnology Main Business Overview
11.16.5 Goodwin Biotechnology Latest Developments
12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Antibody Drug Conjugates Contract Manufacturing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of IgG1
Table 3. Major Players of IgG2
Table 4. Major Players of IgG4
Table 5. Antibody Drug Conjugates Contract Manufacturing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type (2017-2022)
Table 8. Antibody Drug Conjugates Contract Manufacturing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application (2017-2022)
Table 11. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Player (2020-2022)
Table 13. Antibody Drug Conjugates Contract Manufacturing Key Players Head office and Products Offered
Table 14. Antibody Drug Conjugates Contract Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Regions (2017-2022)
Table 19. Americas Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Country (2017-2022)
Table 21. Americas Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type (2017-2022)
Table 23. Americas Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application (2017-2022)
Table 25. APAC Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Region (2017-2022)
Table 27. APAC Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type (2017-2022)
Table 29. APAC Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application (2017-2022)
Table 31. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Country (2017-2022)
Table 33. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type (2017-2022)
Table 35. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Antibody Drug Conjugates Contract Manufacturing
Table 44. Key Market Challenges & Risks of Antibody Drug Conjugates Contract Manufacturing
Table 45. Key Industry Trends of Antibody Drug Conjugates Contract Manufacturing
Table 46. Global Antibody Drug Conjugates Contract Manufacturing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Antibody Drug Conjugates Contract Manufacturing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Antibody Drug Conjugates Contract Manufacturing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share Forecast by Application (2023-2028)
Table 52. Lonza Group Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 53. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 54. Lonza Group Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Lonza Group Main Business
Table 56. Lonza Group Latest Developments
Table 57. Piramal Pharma Solutions Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 58. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 59. Piramal Pharma Solutions Main Business
Table 60. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Piramal Pharma Solutions Latest Developments
Table 62. Abbvie Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 63. Abbvie Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 64. Abbvie Main Business
Table 65. Abbvie Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Abbvie Latest Developments
Table 67. Novasep Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 68. Novasep Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 69. Novasep Main Business
Table 70. Novasep Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Novasep Latest Developments
Table 72. Merck Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 73. Merck Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 74. Merck Main Business
Table 75. Merck Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Merck Latest Developments
Table 77. Cambrex Corporation Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 78. Cambrex Corporation Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 79. Cambrex Corporation Main Business
Table 80. Cambrex Corporation Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Cambrex Corporation Latest Developments
Table 82. Recipharm Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 83. Recipharm Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 84. Recipharm Main Business
Table 85. Recipharm Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Recipharm Latest Developments
Table 87. Thermo Fisher Scientific Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 88. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 89. Thermo Fisher Scientific Main Business
Table 90. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Thermo Fisher Scientific Latest Developments
Table 92. Cerbios-Pharma Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 93. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 94. Cerbios-Pharma Main Business
Table 95. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Cerbios-Pharma Latest Developments
Table 97. Sterling Pharma Solutions Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 98. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 99. Sterling Pharma Solutions Main Business
Table 100. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Sterling Pharma Solutions Latest Developments
Table 102. ADC Biotechnology Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 103. ADC Biotechnology Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 104. ADC Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. ADC Biotechnology Main Business
Table 106. ADC Biotechnology Latest Developments
Table 107. Ajinomoto Bio-Pharma Services Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 108. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 109. Ajinomoto Bio-Pharma Services Main Business
Table 110. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Ajinomoto Bio-Pharma Services Latest Developments
Table 112. BOC Sciences Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 113. BOC Sciences Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 114. BOC Sciences Main Business
Table 115. BOC Sciences Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. BOC Sciences Latest Developments
Table 117. BSP Pharmaceuticals Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 118. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 119. BSP Pharmaceuticals Main Business
Table 120. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. BSP Pharmaceuticals Latest Developments
Table 122. CARBOGEN AMCIS Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 123. CARBOGEN AMCIS Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 124. CARBOGEN AMCIS Main Business
Table 125. CARBOGEN AMCIS Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. CARBOGEN AMCIS Latest Developments
Table 127. Goodwin Biotechnology Details, Company Type, Antibody Drug Conjugates Contract Manufacturing Area Served and Its Competitors
Table 128. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product Offered
Table 129. Goodwin Biotechnology Main Business
Table 130. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Goodwin Biotechnology Latest Developments
List of Figures
List of Figures
Figure 1. Antibody Drug Conjugates Contract Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type in 2021
Figure 7. Antibody Drug Conjugates Contract Manufacturing in Solid Tumors
Figure 8. Global Antibody Drug Conjugates Contract Manufacturing Market: Solid Tumors (2017-2022) & ($ Millions)
Figure 9. Antibody Drug Conjugates Contract Manufacturing in Hematological Malignancies
Figure 10. Global Antibody Drug Conjugates Contract Manufacturing Market: Hematological Malignancies (2017-2022) & ($ Millions)
Figure 11. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application in 2021
Figure 12. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Player in 2021
Figure 13. Global Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Antibody Drug Conjugates Contract Manufacturing Market Size 2017-2022 ($ Millions)
Figure 15. APAC Antibody Drug Conjugates Contract Manufacturing Market Size 2017-2022 ($ Millions)
Figure 16. Europe Antibody Drug Conjugates Contract Manufacturing Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size 2017-2022 ($ Millions)
Figure 18. Americas Antibody Drug Conjugates Contract Manufacturing Value Market Share by Country in 2021
Figure 19. Americas Antibody Drug Conjugates Contract Manufacturing Consumption Market Share by Type in 2021
Figure 20. Americas Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application in 2021
Figure 21. United States Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Region in 2021
Figure 26. APAC Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application in 2021
Figure 27. China Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Country in 2021
Figure 34. Europe Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type in 2021
Figure 35. Europe Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application in 2021
Figure 36. Germany Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size Market Share by Application in 2021
Figure 44. Egypt Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Antibody Drug Conjugates Contract Manufacturing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 50. APAC Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 51. Europe Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 53. United States Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 54. Canada Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 57. China Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 58. Japan Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 59. Korea Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 61. India Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 62. Australia Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 63. Germany Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 64. France Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 65. UK Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 66. Italy Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 67. Russia Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 68. Spain Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 71. Israel Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Antibody Drug Conjugates Contract Manufacturing Market Size 2023-2028 ($ Millions)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets